檢索結果 - Alexandra Benouaich‐Amiel
- Showing 1 - 6 results of 6
-
1
-
2
-
3
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomi... 由 Jay‐Jiguang Zhu, Petya Demireva, Andrew A. Kanner, Susan C. Pannullo, H. Maximilian Mehdorn, Nicholas G. Avgeropoulos, Andrea Salmaggi, Antonio Silvani, Samuel Goldlust, Carlos A. David, Alexandra Benouaich‐Amiel
出版 2017Artigo -
4
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer 由 Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer, Adva Levy‐Barda, Shlomit Yust‐Katz, Alona Zer, Alexandra Benouaich‐Amiel, Haim Ben‐Zvi, Neta Moskovits, Baruch Brenner, Jihad Bishara, Dafna Yahav, Boaz Tadmor, Tal Zaks, Salomon M. Stemmer
出版 2021Artigo -
5
Temozolomide for low-grade gliomas 由 Gentian Kaloshi, Alexandra Benouaich‐Amiel, F. Diakité, Sophie Taillibert, Julie Lejeune, Florence Laigle–Donadey, M.-A Renard, Wafae Iraqi, Ahmed Idbaïh, S. Paris, L. Capelle, Hugues Duffau, Philippe Cornu, Julien Simon, Karima Mokhtari, M. Polivka, Antonio Omuro, Alain Carpentier, Marc Sanson, J.‐Y. Delattre, Khê Hoang‐Xuan
出版 2007Artigo -
6
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network 由 Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain, Hervé Ghesquières, Olivier Chinot, Luc Taillandier, Pierre Soubeyran, T. Lamy, Franck Morschhauser, Alexandra Benouaich‐Amiel, Guido Ahle, Marie‐Pierre Moles‐Moreau, Cécile Moluçon‐Chabrot, Pascal Bourquard, Ghandi Damaj, Fabrice Jardin, Delphine Larrieu‐Ciron, Emmanuel Gyan, Rémy Gressin, Arnaud Jaccard, Sylvain Choquet, Annie Brion, Olivier Casasnovas, Philippe Colin, Oumédaly Reman, Adrian Tempescul, Jean‐Pierre Marolleau, Michel Fabbro, Florian Naudet, Khê Hoang‐Xuan, Roch Houot
出版 2016Artigo
相關主題
Internal medicine
Medicine
Oncology
Biology
Cancer research
Surgery
Temozolomide
Allele
Cancer
Chemotherapy
Gene
Genetics
Loss of heterozygosity
Multivariate analysis
Progression-free survival
Radiation therapy
Univariate analysis
Antibody
Antibody titer
Astrobiology
Biochemistry
CDKN2A
CDKN2B
Carcinogenesis
Clinical endpoint
Cohort
Complete response
Concomitant
Environmental health
Exon